Technical evaluation of the first fully automated assay for the detection of TSH receptor autoantibodies

Clinica Chimica Acta

Volumn 401, Issue 1-2, 2009, Pages 84-89

  Hermsen, Derik ^a   Broecker Preuss, Martina ^b   Casati, Marco ^c   Mas, Jordi Camara ^d   Eckstein, Anja ^b   Gassner, Dieter ^e   van Helden, Josef ^f   Inomata, Keiko ^g   Jarausch, Jochen ^e   Kratzsch, Jürgen ^h   Mann, Klaus ^b   Miyazaki, Naoko ⁱ   Navarro Moreno, Miguel Angel ^d   Murakami, Tsukasa ^g   Roth, Heinz Jürgen ^j   Noh, Jaeduk Yoshimura ⁱ   Scherbaum, Werner A ^a   Schott, Matthias ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c SAN GERARDO HOSPITAL   (Italy)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e ROCHE DIAGNOSTICS GMBH   (Germany)

^f Medical Center for Laboratory Medicine   (Germany)

^g Hospital Foundation   (Japan)

^h UNIVERSITY HOSPITAL LEIPZIG   (Germany)

ⁱ ITO HOSPITAL   (Japan)

^j Limbach Laboratory   (Germany)

more..

Author keywords

Automated TRAb assay; Graves' disease; M22 human monoclonal antibody

Indexed keywords

AUTOANTIBODY; HUMAN MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY M22; THYROTROPIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; GRAVES DISEASE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THYROID DISEASE;

ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; CHEMILUMINESCENT MEASUREMENTS; GRAVES DISEASE; HUMANS; IMMUNOASSAY; MICE; RECEPTORS, THYROTROPIN; SENSITIVITY AND SPECIFICITY; SWINE;

SUS;

EID: 58549090295     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.11.025     Document Type: Article

References (28)

1. Weetman A.P. Graves' disease. N Engl J Med 343 (2000) 1236-1248
2. Pedersen I.B., Knudsen N., Perrild H., Ovesen L., and Laurberg P. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays. Clin Endocrinol (Oxf) 55 (2001) 381-390
3. Paunkovic J., and Paunkovic N. Does autoantibody-negative Graves' disease exist? A second evaluation of the clinical diagnosis. Horm Metab Res 38 (2006) 53-56
4. Schott M., Scherbaum W.A., and Morgenthaler N.G. Thyrotropin receptor autoantibodies in Graves' disease. Trends Endocrinol Metab 16 (2005) 243-248
5. Smith B.R., Sanders J., and Furmaniak J. TSH receptor antibodies. Thyroid 17 (2007) 923-938
6. Luton D., Le G.I., Vuillard E., et al. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab 90 (2005) 6093-6098
7. Abalovich M., Amino N., Barbour L.A., et al. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 92 (2007) S1-47
8. Chan G.W., and Mandel S.J. Therapy insight: management of Graves' disease during pregnancy. Nat Clin Pract Endocrinol Metab 3 (2007) 470-478
9. Schott M., Morgenthaler N.G., Fritzen R., et al. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease. Horm Metab Res 36 (2004) 92-96
10. Quadbeck B., Hoermann R., Roggenbuck U., Hahn S., Mann K., and Janssen O.E. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease. Thyroid 15 (2005) 1047-1054
11. Carella C., Mazziotti G., Sorvillo F., et al. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period. Thyroid 16 (2006) 295-302
12. Eckstein A.K., Plicht M., Lax H., et al. Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 91 (2006) 3464-3470
13. Morgenthaler N.G. New assay systems for thyrotropin receptor antibodies. Curr Opin Endocrinol Diabetes 6 (1999) 251-260
14. Sanders J., Jeffreys J., Depraetere H., et al. Thyroid-stimulating monoclonal antibodies. Thyroid 12 (2002) 1043-1050
15. Smith B.R., Bolton J., Young S., et al. A new assay for thyrotropin receptor autoantibodies. Thyroid 14 (2004) 830-835
16. Kamijo K. TSH-receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto's thyroiditis: a comparison of two two-step assays, coated plate ELISA using porcine TSH-receptor and coated tube radioassay using human recombinant TSH-receptor. Endocr J 50 (2003) 113-116
17. Kamijo K. TSH-receptor antibodies determined by the first, second and third generation assays and thyroid-stimulating antibody in pregnant patients with Graves' disease. Endocr J 54 (2007) 619-624
18. Liu C., Hermsen D., Domberg J., et al. Comparison of M22-based ELISA and human-TSH-receptor-based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases. Horm Metab Res 40 (2008) 479-483
19. Gassner D., Golla R., Stock W., Yoshimura Noh J., Sanders J., and Rees Smith B. Development of a new automated assay for thyrotropin receptor autoantibodies on the Elecsys system. Clin Chem 53 6 Suppl (2007) C-135
20. Zweig M.H., and Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39 (1993) 561-577
21. Passing H., and Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem 21 (1983) 709-720
22. Chen C.R., Pichurin P., Nagayama Y., Latrofa F., Rapoport B., and McLachlan S.M. The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim. J Clin Invest 111 (2003) 1897-1904
23. Nagayama Y., and Rapoport B. Thyroid stimulatory autoantibodies in different patients with autoimmune thyroid disease do not all recognize the same components of the human thyrotropin receptor: selective role of receptor amino acids Ser25-Glu30. J Clin Endocrinol Metab 75 (1992) 1425-1430
24. Sanders J., Oda Y., Roberts S., et al. The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor. J Clin Endocrinol Metab 84 (1999) 3797-3802
25. Morgenthaler N.G., Tremble J., Huang G., Scherbaum W.A., McGregor A.M., and Banga J.P. Binding of antithyrotropin receptor autoantibodies in Graves' disease serum to nascent, in vitro translated thyrotropin receptor: ability to map epitopes recognized by antibodies. J Clin Endocrinol Metab 81 (1996) 700-706
26. Atger M., Misrahi M., Young J., et al. Autoantibodies interacting with purified native thyrotropin receptor. Eur J Biochem 265 (1999) 1022-1031
27. Zophel K., von L.P., Roggenbuck D., Wunderlich G., Kotzerke J., and Lackner K.J. Are porcine and human TSH receptor antibody measurements comparable?. Clin Lab 54 (2008) 1-8
28. Hermsen D., Liu C., Domberg J., et al. Comparison of a solid phase human - versus porcine - thyrotropin receptor-based immunoassay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases. Exp Clin Endocrinol Diabetes 116 Suppl 1 (2008) S59-S63